Canada Markets closed

Abbvie Drops by a Record as Allergan Deal Fails to End Doubts

Rebecca Spalding and Riley Ray Griffin
Abbvie Drops by a Record as Allergan Deal Fails to End Doubts

(Bloomberg) -- AbbVie Inc. agreed to pay $63 billion for rival drugmaker Allergan Plc, the latest merger in an industry where some of the biggest companies have been willing to pay a big premium to resolve questions about their growth prospects.

The price tag caused heartburn on Wall Street, and AbbVie had its worst day of trading since it was spun off from former parent Abbott Laboratories. The stock closed down 16% to $65.70 in New York.

Allergan shares finished the day up 25% to $162.43. AbbVie will pay $188.24 a share in cash and stock, according to a statement, a 45% premium to Allergan’s closing price on Monday.

“Allergan, with its well-known Botox, is being used to smooth the wrinkles this time not of a face but of a company,” said David Maris, an analyst with Wells Fargo. “While this is a good alternative for Allergan versus the current share price, we are not convinced that this is a better long-term alternative for shareholders.”

The proposed takeover doesn’t give AbbVie a pipeline full of potential blockbuster drugs, but it buys the company time to develop more. Allergan provides AbbVie with a set of products big enough to diversify its revenue from Humira, the rheumatoid arthritis injection that is the world’s biggest-selling drug worldwide, with about $20 billion in sales last year. Allergan, which is heavily reliant on the wrinkle reducer Botox, will get a profitable exit for shareholders after a four-year slide.

While they use cost savings from the deal to shore up profits, the companies will still be under pressure to show investors they can come up with the next big thing. AbbVie may be nearing the limits of how far it can boost Humira’s price as cheaper competitors come to market, a problem Allergan is already grappling with as more alternatives to Botox emerge.

The companies have developed several potentially promising medicines for a range of diseases, though so far none have convinced investors that they can attract the vast pool of patients that take medications like Humira.

On a conference call announcing the deal, AbbVie Chief Executive Officer Richard Gonzalez, who will lead the combined company, said the transaction should ease concerns about future competition to Humira, adding that the drug is lucrative enough to bankroll the purchase of its eventual successor.

“This is a transformation transaction that provides important strategic benefits for both AbbVie and Allergan,” Gonzalez said. “This will have a profound impact on AbbVie’s overall growth story.”

Gonzalez said on the call with investors that the transaction “isn’t highly dependent on pipeline.”

One drug considered to be a contender to replace some of Humira’s sales over the long term is AbbVie’s Skyrizi, a new psoriasis treatment that many patients may find more convenient than Humira, as it needs to be injected less frequently.

“Patients love Skyrizi, it’s a big contender,” said Mark Lebwohl, the Waldman Chair of Dermatology at the Icahn School of Medicine at Mount Sinai in New York. “It’s four shots a year and appears to be incredibly effective. AbbVie already knows how to sell this drug.”

Size Scrutiny

The drop in North Chicago, Illinois-based AbbVie’s shares Tuesday also reflects investors’ concerns over activist opposition and regulatory scrutiny. Earlier this year, Bristol-Myers Squibb Co. faced opposition from some top investors to abandon its $74 billion acquisition of Celgene Corp. The transaction eventually won the backing of a majority of shareholders, but Bristol-Myers shares are still trading well below their pre-deal value.

On Monday, Bristol-Myers said that it had agreed to divest one of Celgene’s top products, the psoriasis pill Otezla, in order to appease regulators at the U.S. Federal Trade Commission. While there are few major areas of overlap between Allergan and AbbVie, the deal is almost certain to get a careful look from regulators. The company does plan to divest two Allergan drugs, IL-23 and Zenpep, to ensure the deal passes muster, Gonzalez said.

Still, AbbVie’s acquisition is evidence that the world’s biggest drugmakers believe bigger is better. Along with Bristol-Myers’s deal for Celgene, Japan’s Takeda Pharmaceutical Co. earlier this year completed a $62 billion takeover of Shire Plc. A combined AbbVie and Allergan will have sales of about $48 billion, the companies said in a statement, making it one of the biggest in the industry.

Back to the U.S.

The deal will return Allergan to the U.S., at least for tax purposes. While the company is run from New Jersey, it moved its domicile to Dublin in 2015 via another merger, partly to take advantage of lower corporate rates abroad. The 2017 U.S. tax overhaul cut corporate levies to 21% from 35%, which reduced incentives for companies to relocate overseas.

AbbVie currently pays far less in tax than that, however, and has said it will have an effective rate of 9% this year. It has projected its effective rate will rise to 13%.

Allergan CEO Brent Saunders had spent months turning over plans for the drugmaker’s future as its stock price dropped from a 2015 peak of almost $340. Those options included selling off the company’s gastrointestinal drugs or women’s health unit, which would have left it more focused on its profitable medical aesthetics line that includes Botox.

AbbVie said it expects at least $2 billion in annual pretax synergies and other cost reductions in year three of the deal.

Allergan holders will receive 0.8660 AbbVie shares and $120.30 in cash for each share they hold. AbbVie will take on Allergan’s debt, which totaled about $24 billion at the end of the first quarter.

Two Allergan directors, including Saunders, will join AbbVie’s board after the purchase is completed, according to the statement. Gonzalez said on the call that he intends to stay with the company at least through Humira’s loss of exclusivity in the U.S.

The deal is expected to close in early 2020, the companies said.

Morgan Stanley & Co. acted as AbbVie’s financial adviser and Kirkland & Ellis LLP and McCann FitzGerald were legal advisers. JPMorgan Chase & Co. was AbbVie’s financial adviser, and Wachtell, Lipton, Rosen & Katz and Arthur Cox gave legal advice. PJT Partners Inc. was a co-financial adviser to AbbVie.

--With assistance from Marthe Fourcade, Liana Baker and Cynthia Koons.

To contact the reporters on this story: Rebecca Spalding in Boston at rspalding@bloomberg.net;Riley Ray Griffin in New York at rgriffin42@bloomberg.net

To contact the editors responsible for this story: Drew Armstrong at darmstrong17@bloomberg.net, Timothy Annett, Mark Schoifet

For more articles like this, please visit us at bloomberg.com

©2019 Bloomberg L.P.

  • Finance
    Bloomberg

    House Democrats to Announce Climate Change Plan: Campaign Update

    (Bloomberg) -- Top House Democrats on Tuesday will announce a new plan for addressing climate change, as congressional inaction threatens to undermine environmental pitches by presidential candidates on an issue that voters identify as a priority.The effort by Democratic leaders on the House Energy and

  • Coca-Cola, Chipotle, Snap earnings — What to know in markets Tuesday
    Finance
    Yahoo Finance

    Coca-Cola, Chipotle, Snap earnings — What to know in markets Tuesday

    Earnings kick into high gear Tuesday, as Coca-Cola, Chipotle and Snap take the spotlight.

  • Veteran energy analyst sees 'generational' opportunity in big oil stocks
    Finance
    Yahoo Finance

    Veteran energy analyst sees 'generational' opportunity in big oil stocks

    A veteran oil analyst sees a "generational" opportunity in big oil stocks, which are paying high dividend yields and have lagged oil prices this year.

  • Finance
    Bloomberg

    Polygamists Admit $512 Million Fraud for U.S. Fuel-Tax Credits

    (Bloomberg) -- Four family members belonging to a Utah polygamist group admitted defrauding the U.S. of $512 million in renewable-fuel tax credits, with the leader saying the mastermind was an Armenian immigrant who owns a small oil and gas empire in Southern California. That businessman now faces trial

  • Finance
    The Canadian Press

    Halliburton and DaVita rise while Cal-Maine and Lennox fall

    NEW YORK — Stocks that moved substantially or traded heavily on Monday:Halliburton Co., up $1.99 to $23.74The oil and gas drilling services company solidly beat Wall Street's second quarter profit forecasts.Circor International Inc., up $1.10 to $39.84A majority of shareholders at the industrial

  • Finance
    The Canadian Press

    Police investigate if Tesla was self-driving during crash

    SAN FRANCISCO — A woman was arrested after running a red light in a rented Tesla in San Francisco and causing a crash that killed a tourist and left his wife critically injured, authorities said Monday.Officers were investigating whether the Tesla, which was rented through the peer-to-peer car rental

  • Bloomberg Market Wrap 7/22: Global Growth, Oil, Southwest Airlines
    Finance
    Bloomberg

    Bloomberg Market Wrap 7/22: Global Growth, Oil, Southwest Airlines

    Jul.22 -- Bloomberg market reporters take a deep dive into all of today's action.

  • Elevated opioid risks found at Native American hospitals
    Finance
    The Canadian Press

    Elevated opioid risks found at Native American hospitals

    FLAGSTAFF, Ariz. — U.S. government hospitals put Native American patients at increased risk for opioid abuse and overdoses, failing to follow their own protocols for prescribing and dispensing the drugs, according to a federal audit made public Monday.The report by the U.S. Department of Health and Human

  • Microsoft pays $25 million to settle corruption charges
    Finance
    The Canadian Press

    Microsoft pays $25 million to settle corruption charges

    NEW YORK — Microsoft is paying more than $25 million to settle federal corruption charges involving a bribery scheme in Hungary and other foreign offices.The U.S. Securities and Exchange Commission said Microsoft will pay about $16.6 million to settle charges that it violated the Foreign Corrupt Practices

  • Finance
    The Canadian Press

    Markets Right Now: Tech gains, but other sectors stumble

    NEW YORK — The latest on developments in financial markets (all times local):4 p.m.It was a good day for big technology stocks on Wall Street but a middling to crummy day for everyone else.Apple rose 2.3% Monday and Intel climbed 2.1%, leading the tech sector to the biggest gains of the day.Just under

  • Finance
    Bloomberg

    SNC Tests Caisse’s Patience With New Profit Warning, Charge

    (Bloomberg) -- SNC-Lavalin Group Inc.’s largest shareholder is losing patience.The Caisse de Depot et Placement du Quebec said the embattled engineering firm’s deteriorating performance is “a cause of growing concern” after it said it would take a C$1.9 billion ($1.45 billion) charge and issued its third

  • Stock market news: July 22, 2019
    Finance
    Yahoo Finance

    Stock market news: July 22, 2019

    U.S. stocks ended slightly higher Monday at the start of a crowded week for corporate earnings. Meanwhile, crude oil prices added to Friday’s gains as tensions escalated with Iran.

  • Starbucks to license mobile technology, taking a page from Amazon's cloud playbook
    Finance
    Yahoo Finance

    Starbucks to license mobile technology, taking a page from Amazon's cloud playbook

    Starbucks will license parts of its mobile and loyalty technology to build a new cloud-based platform for the broader restaurant industry.

  • Tech Shares Lead Gains Before Earnings; Oil Rises: Markets Wrap
    Finance
    Bloomberg

    Tech Shares Lead Gains Before Earnings; Oil Rises: Markets Wrap

    (Bloomberg) -- Technology shares led gains among U.S. stocks following mixed sessions in Europe and Asia as investors looked ahead to a busy week of corporate earnings. Oil gained amid tensions in the Persian Gulf.Apple rallied after Morgan Stanley boosted its price target, while Micron Technology was

  • Elizabeth Warren’s economic doomsaying
    Finance
    Yahoo Finance

    Elizabeth Warren’s economic doomsaying

    Voters may be surprised to learn that everything is terrible.

  • State says not so fast on fake German heiress' Netflix deal
    Finance
    The Canadian Press

    State says not so fast on fake German heiress' Netflix deal

    NEW YORK — Prosecutors have asked a New York judge to prevent the con artist Anna Sorokin from cashing in on a Netflix production expected to highlight the extravagant ruse that landed the woman who posed as a German heiress in state prison.The New York Attorney General's Office recently challenged

  • What to expect when Snap reports 2Q results
    Finance
    Yahoo Finance

    What to expect when Snap reports 2Q results

    Snap reports second-quarter earnings results after market close on Tuesday.

  • Expert warns of Huawei monopoly in North, leaving residents vulnerable to China
    Finance
    The Canadian Press

    Expert warns of Huawei monopoly in North, leaving residents vulnerable to China

    Ottawa is creating conditions for the telecom giant Huawei to create a monopoly on high-speed internet in Canada's Far North, leaving its residents vulnerable to Beijing's will, says a leading analyst.Michael Byers, an Arctic-affairs expert at the University of British Columbia, said there'

  • After bailouts, Greece wants easier budget targets
    Finance
    The Canadian Press

    After bailouts, Greece wants easier budget targets

    ATHENS, Greece — Greece's new conservative government says it wants to ease tough budget restrictions set by bailout lenders two years ahead of schedule, as lawmakers prepared Monday to formally confirm the new administration.Government spokesman Stelios Petsas said Athens will seek negotiations

  • 'This market needs the Fed to lower rates': analyst
    Finance
    Yahoo Finance

    'This market needs the Fed to lower rates': analyst

    We’re about one week away until the next Federal Open Market Committee’s policy-setting meeting, with many expecting a cut in interest rates. Fearless Wealth CIO RC Peck told Yahoo Finance’s YFi AM, that he believes a rate cut is imperative to our current market.

  • Philadelphia Energy Files for Chapter 11 Bankruptcy After June Explosion
    Finance
    Bloomberg

    Philadelphia Energy Files for Chapter 11 Bankruptcy After June Explosion

    (Bloomberg) -- Philadelphia Energy Solutions filed for bankruptcy protection and reached a financing agreement with debt holders as the fuel-making company grapples with the aftermath of a June explosion and fire at its oil refinery that forced it to shut operations.The company submitted Chapter 11 petitions

  • Apple Hires Tesla Engineer With Interior Design Experience
    Finance
    Bloomberg

    Apple Hires Tesla Engineer With Interior Design Experience

    (Bloomberg) -- Apple Inc. has hired Steve MacManus, at least the third Tesla Inc. engineering executive to join the Cupertino, California-based technology giant in the last year.MacManus, a Tesla vice president in charge of engineering for car interiors and exteriors, left the carmaker recently and has

  • Tech Giants' White House Meeting Sets Stage for U.S.-China Talks
    Finance
    Bloomberg

    Tech Giants' White House Meeting Sets Stage for U.S.-China Talks

    (Bloomberg) -- The U.S. and China are moving closer to their first face-to-face trade negotiations in months, with a meeting between tech executives and senior White House officials on Monday expected to mark another step toward easing a ban on sales to China’s Huawei Technologies Co.The White House

  • Oil Advances Most in a Week as Middle East Tensions Persist
    Finance
    Bloomberg

    Oil Advances Most in a Week as Middle East Tensions Persist

    (Bloomberg) -- Oil rose the most in more than a week as Iran’s seizure of a British oil tanker fueled concerns about escalating tensions in the Middle East.Futures closed 1.1% higher in New York on Monday after easing some gains during the session. While the U.K. demanded the immediate release of the

  • Elizabeth Warren’s ‘Economic Crash’ Call Spotlights Democrats’ Line of Attack on Trump
    Finance
    Bloomberg

    Elizabeth Warren’s ‘Economic Crash’ Call Spotlights Democrats’ Line of Attack on Trump

    (Bloomberg) -- Democratic presidential hopeful Elizabeth Warren highlighted burgeoning debt levels and recent declines in manufacturing as factors making the U.S. economy vulnerable to a downturn, previewing a line of attack Donald Trump’s opponents will use to pierce the aura of a record-long expansion